• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Mechanical thrombectomy in COVID-19-associated ischaemic stroke: patient characteristics and outcomes in a single-centre study
CONCLUSION: In AIS patients treated with MT, concomitant SARS-CoV2 infection did not affect the outcome. Our observations need to be confirmed in larger, and preferably multicentre, studies.PMID:35315928 | DOI:10.5603/PJNNS.a2022.0026
Source: Neurologia i Neurochirurgia Polska - March 22, 2022 Category: Neurology Authors: Katarzyna Sawczy ńska Pawe ł Wrona Tomasz K ęsek Marcin Wnuk Robert Chrzan Tomasz Homa Roman Pu łyk Jeremiasz Jagie łła Tadeusz Popiela Agnieszka S łowik Source Type: research

Clinical features of neurological patients with coronavirus 2019: an observational study of one centre.
CONCLUSIONS: We studied a select group of patients (elderly, with comorbidities, and moderate or severe COVID-19 course). Pre-existing neurological disorders were additionally associated with a poorer prognosis and a high fatality rate (30%). Dementia and CNS vascular disorder were the most frequent pre-existing neurological conditions. The neurological symptoms of COVID-19 were various. We observed impaired consciousness, dizziness, headache, nausea, myalgia, psychomotor agitation and slowness, delirium, and psychoses. Further analysis is needed to elucidate the incidence of COVID-19 neurological complications. PMID:...
Source: Neurologia i Neurochirurgia Polska - February 2, 2021 Category: Neurology Authors: Zielińska-Turek J, Jasińska A, Kołakowska J, Szadurska J, Kosior DA, Dorobek M Tags: Neurol Neurochir Pol Source Type: research

Blood-brain barrier function in response to SARS-CoV-2 and its spike protein
Neurol Neurochir Pol. 2023 Feb 22. doi: 10.5603/PJNNS.a2023.0014. Online ahead of print.ABSTRACTThe typical manifestation of coronavirus 2 (CoV-2) infection is a severe acute respiratory syndrome (SARS) accompanied by pneumonia (COVID-19). However, SARS-CoV-2 can also affect t he b rain, c ausing c hronic n eurological s ymptoms, variously known as long, post, post-acute, or persistent COVID-19 condition, and affecting up to 40% of patients. The symptoms (fatigue, dizziness, headache, sleep disorders, malaise, disturbances of memory and mood) usually are mild and resolve spontaneously. However, some patients develop acute ...
Source: Neurologia i Neurochirurgia Polska - February 22, 2023 Category: Neurology Authors: Łukasz Suprewicz Krzysztof Fiedoruk Agata Czarnowska Marcin Sadowski Agnieszka Strzelecka Peter A Galie Paul A Janmey Alina Ku łakowska Robert Bucki Source Type: research

SARS-CoV-2 neurotropism and other possible causes of olfactory disorders in COVID-19
Neurol Neurochir Pol. 2023 Feb 20. doi: 10.5603/PJNNS.a2023.0013. Online ahead of print.ABSTRACTCoronavirus disease 2019 (COVID-19) is an acute infectious respiratory disease (AIRD) caused by infection with the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first cases were diagnosed and reported in Wuhan, central China, in November 2019. The disease initially occurred locally. However, the number of infected individuals increased dynamically and spread worldwide. The most common symptoms of the SARS-CoV-2 infection include malaise, fever, dry cough and dyspnoea. Over time, reports of new COVID-19 sy...
Source: Neurologia i Neurochirurgia Polska - February 22, 2023 Category: Neurology Authors: Pawe ł Sowa Adam Dadok Monika Adamczyk-Sowa Source Type: research

Pages: 1  2